Click Here to View the Activity
This educational activity is specifically designed for endocrinologists, urologists, internists, family practitioners, and healthcare professionals (physician assistants, nurses, nurse practitioners, and pharmacists) with an interest in the comorbidities of hypogonadotropic hypogonadism and diabetes mellitus.
The focus of this Webcast is to increase the awareness among clinicians about patients with the comorbidities of hypogonadotropic hypogonadism and diabetes mellitus (with a focus on hypogonadism). In addition, this educational activity will provide information regarding the possible etiologies of diabetes secondary to hypogonadism and to elucidate the treatment options for patients with these comorbidities to resolve hypogonadism in male patients.
After successful completion of this activity, participants should be able to:
- Discuss and elucidate the pathogenesis of type 2 diabetes in patients with hypogonadotropic hypogonadism
- Evaluate and discuss the clinical presentation of patients with hypogonadotropic hypogonadism
- Review and implement treatment plans for patients with the comorbidities of type 2 diabetes and hypogonadotropic hypogonadism
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), Imedex®, LLC must ensure balance, objectivity, independence, and scientific rigor in its educational activities. Faculty are encouraged to provide a balanced view of therapeutic options by utilizing generic names of several to ensure impartiality.
All faculty participating in an Imedex activity are required to disclose commitments to and/or relationships with pharmaceutical companies, biomedical device manufacturers or distributors, or others whose products or services may be considered to be related to the subject matter of the educational activity. Disclosure of these commitments and/or relationships is included in these course materials so that participants in the activity may formulate their own judgments in interpreting its content and evaluating its recommendations.
All speakers were independently selected by the organizing committee. The following indicates the faculty disclosure declaration information and the nature of those commercial relationships.
All materials are included with the permission of the authors.
1=grant/research support 2=consultant 3=speaker’s bureau 4=stock shareholder 5=other support
| John E. Morley, MB, BCh |
Amgen
Inc.2,3; Ascend Pharmaceuticals
Inc.1; Baxter Pharmaceuticals1,2;
Edunn Biotec2,4; GTx, Inc.3;
Indevus Pharmaceuticals, Inc.2,3;
Mattern Pharmaceuticals AG 2,3,4;
MERCK & CO., Inc.3; Novartis
Pharmaceuticals Corporation2,3;
Novartis Medical Nutrition3; Numico1;
Ortho Biotech Products, L.P. 3 |
The following speakers have reported an affiliation with the supporters of this conference:
| Sandeep S. Dhindsa, MD |
Solvay Pharmaceuticals, Inc.1,3 |
All materials are included with the permission of the authors.
Imedex, LLC Staff Disclosure of Financial Relationships
Imedex, LLC is a subsidiary of AmerisourceBergen Specialty Group, which is a subsidiary of AmerisourceBergen Company. All Imedex staff members, except for the following, who are in a position to control the content of this activity, have no financial relationships with any commercial interests that are relevant to this activity:
Keith Steward, MD, MBA, owns shares of Pfizer Inc and Johnson & Johnson, as well as stock options for AmerisourceBergen.
Chris Bolwell owns shares of GlaxoSmithKline and stock options for AmerisourceBergen.
Kenneth Richardson, MD, Bradley Bongiovanni, ND, and Becky Lynch, RN, own stock options for AmerisourceBergen.
This activity is sponsored by Imedex, LLC.
Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Imedex, LLC designates this educational activity
for a maximum 0.75 of AMA PRA Category 1 Credits™.
Physicians should only claim credit commensurate with the extent
of their participation in the activity.
In order to receive credit, participants must successfully complete the post-test and complete the online evaluation form. You will receive an online CME statement of credit to print for your records.
For questions regarding the accreditation of this activity, please contact
Imedex
4325 Alexander Drive
Alpharetta, GA 30022
Fax: +1(770) 751-7334
Email: elearning@imedex.com
This Webcast may contain information about experimental and other uses of drugs or devices that are not currently approved by the US Food and Drug Administration (FDA) and/or other national regulatory agencies in the United States and other countries. Participants in the United States are encouraged to consult the FDA-approved product labeling for any drug or device mentioned in this program before use. Participants from other countries should consult with their respective regulatory authorities.
The opinions expressed in this Webcast are the opinions of the authors and do not necessarily reflect the opinions of Imedex.
Readers may view, browse, and/or download material
for temporary copying purposes only, provided these uses are
for noncommercial personal purposes. Except as provided by law,
this material may not be further reproduced, distributed, transmitted,
modified, adapted, performed, displayed, published, or sold in
whole or in part, without prior written permission from the publisher.
The following company has provided an unrestricted educational grant in support of this activity:
Solvay Pharmaceuticals, Inc.
Click Here to View the Activity
|
